HOLLISTER, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that Pluristyx’s ...

Cellistic has launched the Echo-NK platform to enable the scalable manufacturing of allogeneic cell therapies to target ...

Cellistic introduces Echo-NK Platform to enable scalable manufacturing of allogeneic cell therapies to target multiple diseases: Mont-Saint-Guibert, Belgium Monday, April 14, 2025 ...

(RTTNews) - Alpha Teknova, Inc. (TKNO) and Pluristyx, Wednesday announced the launch of their proprietary PluriFreeze cryopreservation ... of allogeneic cell therapies. The system includes two ...

“Through our development of iPSCs, we recognized how important it is to choose the right biopreservation reagents to protect cells during both hypothermic storage and cryopreservation, and at ...